A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM)
Resource Type
Article
Authors
Dayimu, Alimu ; Gupta, Avinash ; Matin, Rubeta N. ; Nobes, Jenny ; Board, Ruth ; Payne, Miranda ; Rao, Ankit ; Fusi, Alberto ; Danson, Sarah ; Eccles, Bryony ; Carser, Judith ; Brown, Ciara O’Hanlon ; Steven, Neil ; Bhattacharyya, Madhumita ; Brown, Ewan ; Gonzalez, Michael ; Highley, Martin ; Pickering, Lisa ; Kumar, Satish ; Waterston, Ashita ; Burghel, George ; Demain, Leigh ; Baker, Eleanor ; Wulff, Jerome ; Qian, Wendi ; Twelves, Sophie ; Middleton, Mark ; Corrie, Pippa
Source
In European Journal of Cancer January 2024 196
Subject
MSC
Language
ISSN
0959-8049